Bioactive glasses as delivery systems for antimicrobial agents
- 3 May 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 122 (6) , 1424-1437
Abstract
Most biomaterial-associated infections are caused by opportunistic pathogens and bacteria that are regularly found within the microflora of the implant site. In addition, a biomaterial implant or device remains at risk of infection by hematogenous spread of bacteria disseminated from infections elsewhere in the body or from infected peri-implant tissue in revision surgery. The resulting infections are frequently accompanied by patient morbidity and discomfort and can lead to surgical replacement of the implant after lengthy, unsuccessful attempts to mitigate infections with antibiotic treatments. Therefore, extensive is aiming to find new infection-resistant antimicrobial biomaterials and coatings for implants and devices to effectively reduce the incidence of biomaterial-associated infections. An overview of the in vitro and in vivo antimicrobial efficacies of the numerous biomaterials currently available is beyond the scope of this review. Herein, we provide a comprehensive review of bioactive glasses as biomaterial delivery systems for antimicrobial agents.Keywords
This publication has 109 references indexed in Scilit:
- Bioglass®-based scaffolds incorporating polycaprolactone and chitosan coatings for controlled vancomycin deliveryCeramics International, 2013
- Scaffold technologies for controlling cell behavior in tissue engineeringBiomedical Materials, 2013
- Antibacterial hemostatic dressings with nanoporous bioglass containing silverInternational Journal of Nanomedicine, 2012
- Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applicationsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Porous Bioactive Glass Scaffolds for Local Drug Delivery in Osteomyelitis: Development and In Vitro CharacterizationAAPS PharmSciTech, 2010
- Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitisBone, 2010
- Failure of particulate bioglass to prevent experimental staphylococcal infection of open tibial fracturesJournal of Antimicrobial Chemotherapy, 2008
- Antimicrobial Gallium‐Doped Phosphate‐Based GlassesAdvanced Functional Materials, 2008
- Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implantActa Orthopaedica, 2008
- Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrinBiomaterials, 2004